NA Proactive news snapshot: CytoDyn, Ipsidy, Bragg Gaming Group, Tocvan Ventures …

CytoDyn Inc (OTCQB:CYDY) said Tuesday that the US Food and Drug Administration (FDA) has given the nod for the start of a Phase 2 trial with its lead drug leronlimab to treat coronavirus (COVID-19) in patients with mild to moderate indications. Patients enrolled in the trial are expected to have a treatment window of approximately 6 weeks. Leronlimab is intended to serve as a therapy for patients experiencing respiratory complications as a result of the virus. Separately, CytoDyn also completed a new non-dilutive convertible debt offering with an institutional investor, which provides $15 million of immediately available capital.  Ipsidy Inc (OTCQB:IDTY), which operates an Identity-as-a-Service (IDaaS) platform that delivers biometric identity solutions, said it has made great strides in building “trusted identity” last year, as it reported full-year 2019 financial and business results. In a statement accompanying the New York biometric security specialist’s latest numbers, Ipsidy CEO Philip Beck said: “As a result of our engagement with business partners in 2019, we have finetuned our approach to the market to reflect the solutions that customers are demanding and simplified the way users interact with our solutions.” Bragg Gaming Group Inc (CVE:BRAG) (OTCMKTS:BRGGF) subsidiary ORYX Gaming has said it is supplying its full portfolio of casino games to online gaming powerhouse Lottoland. Lottoland, which is the world’s largest betting operator, will have access to ORYX’s over 8,000 games from its suppliers and any forthcoming releases. Tocvan Ventures Corp (CNSX:TOC) has revealed that this year's fieldwork at the Pilar gold-silver project in Sonora, Mexico has begun, ahead of a potential drill program later in 2020. The aim of the work is to expand the known areas of mineralization; refine structural features that control mineralization; identify new targets and define them for drill testing, the company said in a statement. The work began on March 21, the company added. Orgenesis Inc (NASDAQ:ORGS) announced Tuesday a breakthrough in the field of cell and gene therapy. In a statement, the global biotech said it had "developed a breakthrough and patented manufacturing process" for so-called bioxomes, through its collaboration and licensing agreement with ExcellaBio Ltd. Asterion Cannabis Inc and its wholly-owned subsidiary Asterion (Australia) Pty Ltd are finalizing the development, construction, maintenance and financing of the first phase of a $400 million greenhouse project in Toowoomba, Queensland.  In a statement Tuesday, the privately-owned Vancouver-based company said it has entered into an exclusive Definitive Association Agreement (DAA) with entities within the Watpac Limited group.   Watpac is a large and well-known contractor in Australia and part of the BESIX Group, a global construction, property development and concessions company. The Flowr Corporation (CVE:FLWR) (OTCMKTS:FLWPF) has received a key licence, which now allows it to release final product into the European market, the cannabis firm told investors on Tuesday. The group said its subsidiary in Europe, Holigen has received Good Manufacturing Practice (GMP) certification in accordance with European Union standards, for its manufacturing facility in Sintra, Portugal. Milestone Scientific Inc (NYSEAMERICAN:MLSS) announced Tuesday that it is advancing the commercial rollout of its CompuFlo Epidural system. The medical device company’s system, a computer-controlled, real-time pressure-sensing technology, is designed to reduce failure rates and accidental punctures. "We have made significant strides in 2019 in order to commercialize our CompuFlo Epidural System in 2020,” Milestone's interim CEO Leonard Osser said in a statement.   Phunware Inc (NASDAQ:PHUN) posted full-year 2019 results after the close on Monday, which revealed the enterprise cloud company transitioning from one-time transaction revenue to multi-year subscription and service revenue. The company, which offers a fully integrated enterprise cloud platform for mobile that provides products, solutions, data and services for brands, brought in $19.2 million in net revenue in 2019, albeit down from $30.9 million the year prior. Q BioMed Inc (OTCQB:QBIO) has announced the appointment of Geoff Fatzinger as its head of regulatory affairs to focus on the company's global regulatory approval strategy to commercialize its lead cancer bone pain product - the non-opioid Strontium89. "We are very happy to have Geoff join the team at Q BioMed. His deep global regulatory expertise and strategic leadership is critical as we reach some important milestones, including our effort to globally commercialize Strontium89," Q BioMed CEO Denis Corin said a statement. Global Atomic Corporation (TSE:GLO) (OTCMKTS:GLATF), the uranium and zinc group, said last year was one of great progress as it posted 2019 results. The firm has six uranium exploration permits in the Republic of Niger, including the significant Dasa deposit, and its Electric Arc Furnace Dust (EAFD) business in Turkey via the BST plant converts a waste product into zinc concentrate. Great Panther Mining Limited (TSE:GPR) (NYSEAMERICAN:GPL) has told investors that it aims this year to ramp up exploration, expand its resources and improve its finances as the group reported its 2019 financial results. Last year, the precious metals producer bought the Tucano gold mine in Brazil, which led to a jump in revenue for the year to end December. The company also operates two Mexican mines - the Topia mine and the Guanajuato Mine Complex (GMC). Great Panther Mining also said that two technical reports regarding the Guanajuato Mine Complex have been filed. The reports are titled "NI 43-101 Mineral Resource Update Technical Report on the Guanajuato Mine Complex, San Ignacio Mine, Guanajuato State, Mexico", dated March 17, 2020, and "NI 43-101 Mineral Resource Update Technical Report on the Guanajuato Mine Complex, Guanajuato Mine, Guanajuato State, Mexico", dated March 27, 2020. The Technical Reports are available on the company's website at www.greatpanther.com. Weekend Unlimited Industries Inc (CSE:POT)(FSE:0OS1)(OTCQB:WKULF) revealed Tuesday that it was “rapidly expanding” its branded product portfolio in Oklahoma to keep pace with rising demand. The Vancouver-based company only kicked off sales in late-2019, but its branded products are now available in over 75 dispensaries in “The Sooner State,” and growing in popularity. In a statement, the company said that it had bolstered its sales team in Oklahoma with the addition of two experienced cannabis sales reps to “manage and grow” the company’s “expanding retail relationship network.” ImmunoPrecise Antibodies Ltd. (CVE:IPA) (OTCQB:IPATF) said it has extended the maturity date for $2,000,000 of previously issued debentures from March 26, 2020 to September 26, 2020. The group also announced that it has completed its settlement of $700,00 of previously issued debentures and interest of $46,875 accrued thereon by issuing 1,244,792 common shares at a price of $0.60 per share. It said the purpose of the debt settlement is to reduce the group's ongoing debt obligations of the debentures. The shares being issued will be subject to a four-month hold period expiring on July 27, 2020. The Valens Company (CVE:VLNS) (OTCQX:VLNCF) said it has received conditional approval to list its shares on the main board of the Toronto Stock Exchange. The Kelowna-based company will graduate from the TSX Venture Exchange, a key landmark in the life of a junior publicly-listed company. Mandalay Resources Corporation (TSX:MND, OTCQB:MNDJF) said it has filed its Annual Information Form for the year ended December 31, 2019, and has also filed an updated National Instrument 43-101 (NI 43-101) compliant Technical Report documenting its recent work at its Björkdal gold mine in Sweden and its Costerfield gold-antimony mine in Australia. It said these can be acessed on the company’s website at www.mandalayresources.com. Dunnedin Ventures Inc (CVE:DVI), which is changing its name to Kodiak Copper Corp on Wednesday, said the TSX Venture Exchange has accepted for filing documentation with respect to its non-brokered private placement, announced on March 13, 2020, which will see the issue of 18,614,000 flow-through shares at a purchase price of 10.5 cents each, plus 9,307,000 share purchase warrants at an initial exercise price of 11 cents and a 2-year term to expiry, with 10 placees. Marrone Bio Innovations, Inc. (NASDAQ:MBII), a leading provider of effective and environmentally responsible pest management and plant health products, said its Form S-1 resale registration statement relating to the potential resale of shares of common stock, including common stock issuable upon the exercise of warrants, held by certain shareholders of the company has been declared effective by the US Securities and Exchange Commission on March 30, 2020. Jim Boyd, the company's Chief Financial Officer commented: "We are not offering any new securities, and we will not receive any proceeds from the resale of stock under this Form S-1. However, because this registration statement is now effective, we may continue to receive proceeds from the cash exercise of warrants issued in February 2018 and issuable under our warrant facility."